Fn14 gene expression is elevated in over a dozen different solid tumor types compared with matched adjacent normal tissue or normal tissues from non-diseased donors (8–14); consequently, Fn14 is also a potential target for cancer therapy. This evidence concerns the gene TNFRSF12A and cancer.